These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 23374281)
1. The heparanase/syndecan-1 axis in cancer: mechanisms and therapies. Ramani VC; Purushothaman A; Stewart MD; Thompson CA; Vlodavsky I; Au JL; Sanderson RD FEBS J; 2013 May; 280(10):2294-306. PubMed ID: 23374281 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of heparanase inhibitors in cancer therapy. Heyman B; Yang Y Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132 [TBL] [Abstract][Full Text] [Related]
3. Heparanase regulates levels of syndecan-1 in the nucleus. Chen L; Sanderson RD PLoS One; 2009; 4(3):e4947. PubMed ID: 19305494 [TBL] [Abstract][Full Text] [Related]
4. Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy. Sanderson RD; Elkin M; Rapraeger AC; Ilan N; Vlodavsky I FEBS J; 2017 Jan; 284(1):42-55. PubMed ID: 27758044 [TBL] [Abstract][Full Text] [Related]
5. SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis. Ritchie JP; Ramani VC; Ren Y; Naggi A; Torri G; Casu B; Penco S; Pisano C; Carminati P; Tortoreto M; Zunino F; Vlodavsky I; Sanderson RD; Yang Y Clin Cancer Res; 2011 Mar; 17(6):1382-93. PubMed ID: 21257720 [TBL] [Abstract][Full Text] [Related]
13. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925 [TBL] [Abstract][Full Text] [Related]
14. Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression. Rangarajan S; Richter JR; Richter RP; Bandari SK; Tripathi K; Vlodavsky I; Sanderson RD J Histochem Cytochem; 2020 Dec; 68(12):823-840. PubMed ID: 32623935 [TBL] [Abstract][Full Text] [Related]
15. Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells. Masola V; Gambaro G; Tibaldi E; Onisto M; Abaterusso C; Lupo A Biochim Biophys Acta; 2011 Aug; 1813(8):1475-82. PubMed ID: 21600934 [TBL] [Abstract][Full Text] [Related]
16. Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity. Ramani VC; Yang Y; Ren Y; Nan L; Sanderson RD J Biol Chem; 2011 Feb; 286(8):6490-9. PubMed ID: 21131364 [TBL] [Abstract][Full Text] [Related]
17. Involvement of Syndecan-1 and Heparanase in Cancer and Inflammation. Teixeira FCOB; Götte M Adv Exp Med Biol; 2020; 1221():97-135. PubMed ID: 32274708 [TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate mediates trastuzumab effect in breast cancer cells. Suarez ER; Paredes-Gamero EJ; Del Giglio A; Tersariol IL; Nader HB; Pinhal MA BMC Cancer; 2013 Oct; 13():444. PubMed ID: 24083474 [TBL] [Abstract][Full Text] [Related]
19. Heparanase activates the syndecan-syntenin-ALIX exosome pathway. Roucourt B; Meeussen S; Bao J; Zimmermann P; David G Cell Res; 2015 Apr; 25(4):412-28. PubMed ID: 25732677 [TBL] [Abstract][Full Text] [Related]